BIO-RAD LABORATORIES, INC.
BIO · XNYSCIK 12208fmd_1VYP4MMJSAQA5QP5J64ZT9EZVWManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2008 to Sep 30, 2026, 71 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 2,068 | 2,160 | 2,289 | 2,312 | 2,546 | 2,923 | 2,802 | 2,671 | 2,567 | 2,583 |
| Cost of revenue | 930 | 972 | 1,066 | 1,055 | 1,108 | 1,284 | 1,235 | 1,244 | 1,188 | 1,243 |
| Gross profit | 1,138 | 1,188 | 1,223 | 1,257 | 1,438 | 1,638 | 1,567 | 1,427 | 1,379 | 1,340 |
| Realized investment gains (losses) | 1 | 0 | 2 | 2 | 1 | 8 | 2 | 1 | 7 | 1 |
| Provision for credit losses | – | – | – | – | 0 | 0 | 8 | 0 | 0 | 1 |
| Research and development | 206 | 250 | 199 | 203 | 218 | 261 | 257 | 247 | 296 | 276 |
| Selling, general and administrative | 815 | 807 | 835 | 825 | 799 | 877 | 828 | 842 | 814 | 844 |
| Operating income | 56 | 119 | (103) | 230 | 421 | 500 | 483 | 338 | 269 | 47 |
| Interest expense | 23 | 23 | 24 | 23 | 22 | 2 | 38 | 49 | 49 | 49 |
| Interest and investment income | 15 | 19 | 27 | 31 | 18 | 19 | 58 | 101 | 82 | 96 |
| Other non-operating income (expense) | 0 | 11 | 37 | 26 | 24 | 27 | 45 | 107 | 90 | 90 |
| Income before taxes | 42 | 98 | 513 | 2,261 | 4,918 | 5,449 | (4,704) | (850) | (2,343) | 996 |
| Income tax expense | 16 | (24) | 147 | 502 | 1,104 | 1,195 | (1,077) | (213) | (498) | 236 |
| Net income from continuing operations | 26 | 122 | 366 | 1,759 | 3,814 | 4,254 | (3,627) | (637) | (1,844) | 760 |
| Net income | 26 | 122 | 366 | 1,759 | 3,814 | 4,254 | (3,628) | (637) | (1,844) | 760 |